Incorporation of two doctors to the R&D&I within the "Torres Quevedo" program


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (www.rovi.es) today announced topline results from the pivotal study PRISMA-3, a multicenter,...
4 min
19/03/2019